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Purpose: Treatment with glucocorticoids is a well known risk factor for cataract development, although the pathogenic
mechanism has not been elucidated. The aim of the study was to investigate the effects of glucocorticoids in cultured
human lens epithelial cells.
Methods: Human lens epithelial cells (HLECs) were exposed to dexamethasone for 24 h. The number of viable cells was
determined using the 3-[4, 5-dimethylthiazolyl-2]-2, 5-diphenyltetrazolium bromide (MTT) assay, and proliferation was
quantified using Ki-67. Apoptosis was investigated by measuring caspase-3 activity and by evaluating nuclear morphology
of cells stained with Hoechst 33342. Mitochondria depolarization was measured using the potential-sensitive color, JC-1.
Cells were assayed for changes in superoxide production using dihydroethidium (HET), for alterations in peroxide
production  using  dichlorofluorescein  diacetate  (DCFH-DA),  and  for  glutathione  (GSH)  variations  using
monochlorobimane (MCB). Caspase-3 activity was also measured in HLECs simultaneously exposed to dexamethasone
and the glucocorticoid antagonist, RU486.
Results: Low doses of dexamethasone (0.1 µM) resulted in increased proliferation of HLECs. Apoptosis was increased
in HLECs exposed to 1 µM, 10 µM, and 100 µM of dexamethasone as revealed by nuclear morphology studies. Apoptosis
was also confirmed by measuring caspase-3 activation. No effect on superoxide production by dexamethasone was seen.
There  were  no  effects  on  GSH  levels  or  mitochondrial  depolarization  either.  Only  the  highest  concentration  of
dexamethasone (100 µM) caused an increase in peroxide production. In HLECs incubated with the glucocorticoid
antagonist, RU486, apoptosis was induced at a lower concentration of dexamethasone (0.1 µM) than with dexamethasone
alone.
Conclusions: Low doses of dexamethasone cause a moderate increase in proliferation of cultured HLECs. Slightly higher
but still physiologically relevant concentrations of dexamethasone result in a dose-dependent increase in apoptosis.
Dexamethasone-induced apoptosis in HLECs does not seem to involve oxidative mechanisms. The proapoptotic effect of
dexamethasone does not appear to act through the glucocorticoid receptor. Effects on proliferation and/or dysregulation
of apoptosis in lens epithelial cells may be an important factor in human steroid-induced posterior subcapsular cataract.
It has been well recognized among ophthalmologists for
decades that long-term cortisone therapy, commonly used in
disorders like asthma, allergy, and rheumatoid arthritis or as
an immunosuppressant after transplantation, greatly enhances
the risk of cataract. More specifically, it increases the risk of
posterior subcapsular cataract (PSC), a type of cataract that
often causes substantial impairment of visual acuity being
located centrally on the posterior side of the lens.
It was Black et al. [1], in 1960, who first described the
association between long-term topical and systemic steroid
use and increased occurrence of PSC. Since then, several
reports,  both  clinical  and  experimental,  have  implicated
cataract formation after prolonged glucocorticoid use [2-4].
Solumedrol (methyl prednisolone sodium succinate), acting
on  in  vitro  incubated  rat  lenses,  resulted  in  PSC,  but  an
addition of vitamin E shifted the site of the damage to the lens
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equator [5]. More recently, intravitreal injections with steroids
such as triamcinolone have become frequent in the treatment
of macular edema. A single dose of intravitreal steroids has
been shown to induce PSC [6,7].
Despite the fact that steroid-induced cataract has been and
still is a common clinical condition, the mechanism behind
this  type  of  iatrogenic  lens  opacification  has  not  been
elucidated. It has long been a matter of debate among lens
researchers whether glucocorticoid receptors (GR) exist in the
lens or not, a prerequisite for a receptor-mediated mechanism
to  cataract  development  [8-10].  Several  other  receptor-
independent  mechanisms  for  steroid-induced
cataractogenesis  have  also  been  suggested.  Studies  have
demonstrated  cataract  formation  by  binding  of
glucocorticoids  to  lens  proteins,  resulting  in  changes  of
normal  protein  structure  [11,12],  which  theoretically  may
result in aggregate formation and subsequent light scatter.
Other reports found that covalent binding of steroids was
unlikely to be responsible for steroid-induced cataract [10,
13]. Furthermore, glucocorticoids have been shown to cause
Molecular Vision 2008; 14:1344-1352 <http://www.molvis.org/molvis/v14/a162>
Received 10 April 2008 | Accepted 15 July 2008 | Published 21 July 2008
© 2008 Molecular Vision
1344ion imbalance in the lens [14], but contradictory data exist
[13].
The terminal differentiation of lens epithelial cells into
lens fibers is essential for development and growth of the lens,
a process in which growth factors such as basic fibroblast
growth factor (bFGF) and transforming growth factor beta
TGF-β  play  an  essential  role.  Disturbances  in  the
differentiation process can lead to loss of lens transparency
and thus to cataract development. Studies have suggested that
steroids induce changes in growth factor production in the eye,
leading to an altered impact of these growth factors on lens
epithelial cell differentiation [15].
Another hypothesis states that glucocorticoids may affect
protective antioxidative systems in the lens, thereby making
the  lens  more  susceptible  to  oxidative  stress  [13,15,16].
Dickerson et al. [13] found a decrease in glutathione (GSH)
levels  after  glucocorticoid  exposure.  Another  study
demonstrated protection by vitamin E against damage caused
by  a  soluble  corticosteroid  (methyl  prednisolone  sodium
succinate; solumedrol) in cultured rat lenses [5].
In the present study, we have examined the effect of
dexamethasone  on  cultured  human  lens  epithelial  cells
(HLECs) with respect to proliferation, apoptosis, oxidative
stress, and steroid receptor inhibition.
METHODS
Human lens epithelial cell culture: Human lens epithelium
specimens were obtained from lenses during cataract surgery
at the Eye Clinic, Sahlgrenska University Hospital (Mölndal,
Sweden) after obtaining informed consent. The study was
approved by the Gothenburg University Ethics Committee,
and the tenets of the Declaration of Helsinki were followed.
The  human  lens  epithelium  specimens,  usually  5  mm  in
diameter, were placed into Eppendorf tubes, which contained
culture  medium  (RPMI-1640;  Sigma  Chemical,  St  Louis,
MO) that was supplemented with 10% fetal calf serum, 100
U ml−1 penicillin, 0.1 mg ml−1 streptomycin, and 2 mM L-
glutamine, immediately after surgery. The lens epithelium
specimens were later transferred from the Eppendorf tubes to
24 well culture dishes (TPP, Trasadingen, Switzerland) in a
humidified CO2 incubator at 37 °C to allow the capsule to
attach to the bottom of the culture well. After one to two
weeks, HLECs on the capsules and cells that had migrated
onto  the  bottom  of  the  culture  well  were  detached  by
trypsinization and seeded in cell culture flasks (75 cm2). At
semi-confluency, cells were subcultured by 0.25% trypsin/
EDTA treatment.
For experiments, HLECs from one individual, passage
IV-VIII, were subcultured in medium RPMI-1640 with 10%
fetal  calf  serum,  100  U  ml−1  penicillin,  0.1  mg  ml−1
streptomycin, and 2 mM L-glutamine in a white 96 well plate
with a transparent bottom (Costar Corp., Cambridge, MA)
with approximately 105 cells per well to yield a confluent
monolayer. For Hoechst 33342 labeling, the cells were seeded
in chamber slides with a cover glass bottom (Lab-Tek™ Nalge
Nunc International, Rochester, NY). The chamber glasses
were coated with collagen (0.3 mg/ml; Sigma Chemical, St
Louis, MO) for 15 min after which the slides were allowed to
air dry.
Cell  proliferation  detection  by  immunohistochemistry:
HLECs  cultured  in  chamber  slides  were  exposed  to
dexamethasone for 24 h. After subsequent rinsing in PBS, the
cells were fixed in 4% paraformaldehyde (pH 7.4). The cells
were rinsed in PBS and permeabilized by digitonin (30 µg/ml
in PBS for 10 min at room temperature; Sigma Chemical, St
Louis,  MO).  Following  standard  protocols  for
immunohistochemistry,  the  cells  were  marked  with
monoclonal  mouse  anti-proliferating  cell  protein,  Ki-67
(Sigma),  and  visualized  by  streptavidin-FITC  (Vector
Laboratories, Burlingame, CA). Anti-Ki-67 binds to the Ki-67
nuclear  antigen,  which  is  strictly  associated  with  cell
proliferation. The Ki-67 antigen is expressed by proliferating
cells in all phases of the active cell cycle (G1, S, G2, and M
phase) but absent in resting (G0) cells.
The cells were viewed using a fluorescence microscope
(Nikon Eclipse TE300; Nikon, Tokyo, Japan), and the Ki-67
positive  cells  were  counted.  The  mean  and  SEM  were
calculated  from  three  separate  chamber  slides  and  two
different cell lines.
Effect  of  dexamethasone  on  cell  viability:  MTT  (3-[4,  5-
dimethylthiazolyl-2]-2, 5-diphenyltetrazolium bromide) is a
yellow tetrazolium salt, which is cleaved by mitochondrial
dehydrogenases to purple water-insoluble formazan crystals
in metabolically active cells. The formazan crystals can be
solubilized with acidified isopropanol, and the intensity can
be  measured  colorimetrically  at  a  wavelength  of  570  nm
where the optical density was proportional to the number of
viable cells.
HLECs were cultured in medium RPMI-1640 without
phenol  red  to  80%  confluency  followed  by  exposure  to
dexamethasone for 24 h at 37 °C in a humidified 5% CO2
incubator. MTT diluted 1:10 from a stock solution of 5 mg/
ml in RPMI-1640 without phenol red was added, and the cells
were incubated for 4 h.
Absorption  was  measured  at  570  nm  in  a  microplate
reader (E-max, Molecular Devices, Sunnyvale, CA) using
SOFTmax version 2.01 (Molecular Devices Sunnyvale, CA)
as software, and the difference in optical density between the
sample wavelength (570 nm) and the reference wavelength
(650 nm) was calculated.
Nuclear morphology with Hoechst 33342: To detect and to
quantify apoptosis, HLECs were seeded in collagen coated
chamber slides with a cover glass bottom and incubated with
dexamethasone (0.1 µM, 1 µM, 10 µM, and 100 µM) in
serum-free RPMI-1640 for 24 h at 37 °C in a humidified 5%
CO2  incubator.  The  cells  were  then  fixed  in  4%
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the cells were washed twice in PBS after which cell-permeable
Hoechst  33342  (Hoechst,  Frankfurt  Germany)  was  added
(final concentration 5 µg ml−1 in a HEPES buffer) for 15 min.
After being washed in PBS, glycerol was added to cover the
cells. The cells were immediately viewed using a fluorescence
microscope (Nikon Eclipse TE300; Nikon).
At least 300 cells in three different fields were counted,
and the percentage of apoptotic nuclei in relation to the total
number of cells was determined. The mean and SEM were
calculated from three separate coverslips, and the experiments
were performed in triplicates.
Caspase-3  activity  in  dexamethasone-exposed  human  lens
epithelial cells: HLECs were incubated with dexamethasone
(0.1  µM,  1  µM,  10  µM,  and  100  µM)  in  serum-free
RPMI-1640  that  was  supplemented  with  100  U  ml−1
penicillin, 0.1 mg ml−1 streptomycin, and 2 mM L-glutamine
for 24 h at 37 °C in a humidified 5% CO2 incubator. After the
incubation period, the cells were centrifuged at 350 g for 5
min. The medium was removed, and the well plates were
immediately frozen at −152 °C for at least 30 min. The frozen
HLECs were thawed, and 100 µl of 0.2% CHAPS-containing
buffer  including  the  protease  inhibitors,  trypsin  inhibitors
from  chicken  egg  white  (final  concentration  5  µg  ml−1),
pepstatin (0.5 µg ml−1), leupeptin (1.25 µg ml−1), and PMSF
(0.5 mM; all from Sigma Chemical) were added. The cells
were incubated with the inhibitor-containing CHAPS buffer
for  30  min  at  room  temperature  after  which  20  µl  were
removed for protein determination.
The  synthetic  fluorogenic  substrate,  Ac-Asp-Glu-Val-
Asp-AMC  (Ac-DEVD-AMC;  from  Bachem,  Bubendorf,
Switzerland), used for caspase-3 determination was diluted
from a 10 mM stock solution in water to 50 µM in Tris-HCl
(pH 7.3), 100 mM NaCl, 5 mM EDTA, 1 mM EGTA, and
3 mM NaN3, yielding a final concentration of 25 µM Ac-
DEVD-AMC in the assay. Dithiothreitol was added to a final
concentration of 2 mM.
At the start of the proteolytic assay, 100 µl of substrate
was added to the 96 well plate containing 100 µl of cell lysate
in CHAPS buffer. The fluorescent cleavage product of the
substrate  was  measured  over  time  at  37  °C,  excitation
wavelength 380 nm, emission wavelength 460 nm, using a
microplate  spectrofluorometer  (SPECTRAmax  GEMINI,
Molecular Devices, Sunnyvale, CA). Protease activity was
measured  for  2  h,  and  Vmax  was  determined  in  the  linear
interval  using  SOFTmax  PRO  version  2.6  as  software
(Molecular Devices). Proteolytic activity is expressed as the
increase in relative fluorescence units per second and gram of
protein (RFU s−1g−1).
Protein determination: Aliquots of 20 µl HLECs lysate with
0.2%  CHAPS  buffer  or  hypotonic  buffer  were  taken  for
protein determination using the BCA protein assay reagent
(Pierce Perbio Science UK Limited, Cheshire, UK) with BSA
as the standard. Absorption was measured at 570 nm in a
microplate  reader  (E-max,  Molecular  Devices)  using
SOFTmax version 2.01 as software.
Superoxide  production:  HLECs  were  exposed  to
dexamethasone (0.1 µM, 1 µM, 10 µM, and 100 µM) for 24
h. After subsequent rinsing in PBS, the cells were preloaded
with 5 µM dihydroethidium (HET) (Sigma Chemical) for 10
min at 37 °C. HET was removed, the cells rinsed in PBS, and
RPMI-1640  was  added.  In  cells,  HET  is  oxidized  by
superoxides  to  the  fluorescent  substance  ethidium,  and
changes  in  ethidium  production  can  hence  be  used  as  a
measure of superoxide production. Changes in superoxide
production were continuously measured over time at 37 °C
for  30  min  (excitation  wavelength  510  nm,  emission
wavelength  600  nm).  Vmax  was  determined  in  the  linear
interval  and  is  expressed  as  the  increase  in  relative
fluorescence units per second and gram of protein (RFU s−1g
−1).
Peroxide  production:  Changes  in  peroxide  production  in
dexamethasone exposed (0.1 µM, 1 µM, 10 µM, and 100 µM)
cells were measured using the nonfluorescent DCFH-DA (20
µM). In the cell, DCFH-DA is cleaved by esterases yielding
polarized  nonfluorescent  dichlorofluorescein  (DCFH).
Through peroxides, DCFH is oxidized to fluorescent DCF.
Therefore, the amount of formed DCF is a measure of the
peroxide production in the cell. The cells were incubated with
DCFH-DA for 30 min at 37 °C in a 5% CO2 atmosphere.
Peroxide production was measured (excitation wavelength
490  nm,  emission  wavelength  535  nm)  using  the
SPECTRAmax  GEMINI  spectrofluorometer.  Changes  in
peroxide production are expressed as the increase of relative
fluorescence    units   per    second   and    gram   of   protein
(RFU s−1g−1).
Glutathione  levels  in  dexamethasone-exposed  human  lens
epithelial cells: Monochlorobimane (MCB; 25 µM) in serum
free RPMI-1640 was added to dexamethasone-exposed (0.1
µM, 1 µM, 10 µM, and 100 µM) cells, and changes in the level
of glutathione (GSH) were measured immediately after the
addition of MCB and after 2 h (excitation wavelength 380 nm,
emission wavelength 460 nm). Changes in GSH levels are
expressed as RFU g−1.
Mitochondrial  membrane  potential  in  dexamethasone-
exposed human lens epithelial cells: After subsequent rinsing
in  PBS,  JC-1  (5,5′,6,6’-tetrachloro-1,1’,3,3′-
tetraethylbenzimidazolylcarbocyanine  iodide;  1µM;
Molecular Probes, Eugene, OR) was added to cells exposed
to dexamethasone (0.1 µM, 1 µM, 10 µM, and 100 µM) for
24 h, and the cells were incubated for 15 min at 37 °C. The
cationic dye, JC-1, exhibits potential-dependent accumulation
in the mitochondria. It indicates mitochondria depolarization
by a decrease in the red to green fluorescence intensity ratio.
After incubation with JC-1, the dye was removed; the cells
were rinsed in PBS after which serum-free RPMI-1640 was
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wavelength of 485 nm and the emission wavelength of 535
nm, the red signal at the excitation wavelength of 540 nm and
the emission wavelength of 590 nm, using a SPECTRAmax
microplate spectrofluorometer.
Dexamethasone-exposed JC-1 labeled HLECs were also
studied  by  confocal  microscopy  using  an  argon  laser
(excitation wavelength 488 nm; Nikon C1, Nikon).
Fluorescence  was  plotted  against  time  and  the  linear
interval defined. Proteolytic activity was expressed as relative
fluorescence units per second and gram protein (RFU s−1g−1).
Apoptotic response after glucocorticoid receptor inhibition:
The synthetic GR antagonist, RU486 (10 µM), was added to
HLECs 2 h before the addition of dexamethasone. The cells
were incubated for 24 h at 37 °C in a 5% CO2 atmosphere after
which the substances were removed. Some cells were exposed
to RU-486 alone. After rinsing in PBS, the cells were frozen at
−152 °C for caspase-3 determination as previously described.
Statistics: Data shown are the mean and SEM from triplicate
samples. Each experiment was run at least twice to confirm
reproducibility.  Statistical  analysis  was  performed  using
ANOVA with Dunnett’s as post-hoc. A p value of less than
0.05  was  considered  statistically  significant.  As  statistical
software, SPSS 11.0.4 (SPSS Inc. Chicago, IL), was used.
RESULTS
Immunohistochemical analysis of cell proliferation and cell
viability after dexamethasone exposure: The number of Ki-67
positive cells was increased in HLECs exposed to 0.1 µM
dexamethasone for 24 h whereas higher concentrations had
no significant effect on cell proliferation. However, a trend
toward  increased  proliferation  with  increasing
dexamethasone  concentration  was  evident  (Figure  1).
Exposure  to  dexamethasone  significantly  decreased  the
number  of  viable  HLECs  as  revealed  by  the  MTT  assay
(Figure 2).
Dexamethasone exposure leads to apoptosis in human lens
epithelial cells: When studying nuclear morphology using
Hoechst 33342, increased apoptosis was seen already at 1 µM
dexamethasone  and  the  percentage  of  apoptotic  cells
increased  in  a  dose-dependent  manner  with  higher
dexamethasone  concentrations  (Figure  3A,B).
Dexamethasone at a concentration of 100 µM significantly
increased  caspase-3  activity  in  HLECs  (Figure  3C).  All
incubation periods were for 24 h.
Superoxide/peroxide  production  and  GSH  levels  in
dexamethasone-treated  human  lens  epithelial  cells:
Superoxide  production  in  HLECs  was  not  significantly
changed after exposure to dexamethasone (Figure 4A) for 24
h.  Cells  treated  with  100  µM  dexamethasone  showed
increased peroxide production, which was not present at lower
concentrations (Figure 4B). No effect of dexamethasone on
GSH levels was evident in HLECs after 24 h exposure (Figure
4C).
Mitochondrial membrane potential: No depolarization of the
mitochondrial membrane potential occurred after incubation
with dexamethasone for 24 h as revealed with the JC-1 assay
by quantifying the red to green fluorescence ratio (Figure 5).
Effect  of  dexamethasone  on  caspase-3  activity  after
glucocorticoid receptor inhibition: HLECs were incubated
with increasing concentrations of dexamethasone for 24 h
with  and  without  10  µM  of  the  glucocorticoid  receptor
inhibitor  RU-486,  and  apoptosis  was  determined  by
Figure  1.  Determination  of  cell  proliferation  in  dexamethasone-
exposed human lens epithelial cells. Quantitative determination of
cell proliferation showed an increase in the number of Ki-67 positive
cells in human lens epithelial cells exposed to 0.1 µM dexamethasone
for 24 h whereas higher concentrations of dexamethasone did not
significantly  affect  cell  proliferation.  At  least  300  cells  in  three
different fields were counted. The mean and SEM were calculated
from  three  separate  chamber  slides  (n=3).  The  experiment  was
repeated twice with different cell lines, obtaining similar results.
Figure 2. Number of viable cells after dexamethasone exposure. The
number of viable human lens epithelial cells as determined by the
MTT colorimetric assay was significantly decreased after exposure
to dexamethasone for 24 h. The difference in optical density between
the wavelength of the sample (570 nm) and the reference wavelength
(650 nm) was calculated. Experiments were performed three times
in triplicates (n=3). One representative experimental run is shown.
Mean±SEM are given; the triple asterisk indicates a p<0.001.
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1347measuring caspase-3 activity (Figure 6). This concentration
of  RU-486  (10  µM)  was  chosen  since  it  didn’t  increase
Figure 3. A: Apoptotic morphology of human lens epithelial cells
after  dexamethasone  exposure.  Cells  that  were  exposed  to
dexamethasone exhibited morphologic changes typical of apoptosis
such  as  shrinkage,  chromatin  condensation,  and  nuclear
fragmentation (II and III). Cultured human lens epithelial cells are
shown stained with the nuclear dye Hoechst 33342. Control cells (I)
and cells exposed to 1 µM (II) and 100 µM (III) dexamethasone are
shown. Original magnification 600X. B: Showing increased number
of  apoptotic  cells  after  dexamethasone  exposure.  Human  lens
epithelial  cells  were  exposed  to  dexamethasone  at  different
concentrations during 24 hs after which the cell nuclei were stained
with Hoechst 33342. The percentage of apoptotic cells increased in
a  dose-dependent  manner  with  higher  dexamethasone
concentrations. At least 300 cells from three different chamber slides
were counted. Mean ±SEM are given; the asterisk indicates a p<0.05
and the double asterisk indicates a p<0.01. C: Increased Caspase-3
activity after incubation with dexamethasone. The caspase-3 activity
in cultured human lens epithelial cells was significantly increased
after  the   administration  of  100  µM   dexamethasone   for  24  h.
A  representative  experimental  run  from  three  experiments  with
similar results is shown. Caspase-3 activity is expressed as relative
fluorescence units per second and gram protein (RFU s−1g−1). Mean
±SEM from 3 separate culture wells are shown; the double asterisk
indicates a p<0.01.
apoptosis  when  incubated  with  HLECs  alone.  At  higher
Figure 4. A: Superoxide production in human lens epithelial cells
exposed to dexamethasone. Dexamethasone exposure to human lens
epithelial cells for 24 h had no effect on superoxide production.
Superoxide production was measured over time and expressed as
relative fluorescence units per second and gram protein (RFU s−1g
−1).  The  experiment  was  repeated  twice  with  similar  results.  B:
Peroxide  production  in  human  lens  epithelial  cells  exposed  to
dexamethasone  is  also  demonstrated.  Exposure  of  human  lens
epithelial  cells  to  dexamethasone  for  24  h  resulted  in  increased
peroxide production only at the highest concentration of 100 µM
used.  The  experiment  was  repeated  twice  with  similar  results.
Peroxide production is expressed as relative fluorescence units per
second  and  gram  protein  (RFU  s−1g−1).  Mean±SEM  from  three
separate culture wells are shown; the asterisk indicates a p<0.05. C:
Glutathione  in  human  lens  epithelial  cells  exposed  to
dexamethasone. Dexamethasone did not affect the GSH level in
human lens epithelial cells after incubation with dexamethasone for
24 h. One representative experiment of three is shown. The level of
GSH was measured after 2 h and expressed as relative fluorescence
units and gram protein (RFU x g-1). Mean ±SEM from 3 separate
culture wells is shown.
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1348concentrations, RU-486 caused apoptosis in HLECs by itself,
i.e. without the addition of dexamethasone (not shown). No
protection  of  HLECs  against  dexamethasone-induced
apoptosis was seen by simultaneous incubation with RU-486.
On the contrary, the GR inhibitor, RU-486, increased the
proapoptotic effect of dexamethasone, leading to even more
apoptosis.
DISCUSSION
It  is  now  generally  accepted  that  prolonged  therapy  with
systemic glucocorticoids can cause PSC [1,17]. However, it
is  still  a  matter  of  debate  whether  these  steroid-induced
cataracts are dose dependent [18-21]. Both topically applied
as well as inhaled steroids have also been shown to induce
cataract [22-25].
Dysregulation  of  proliferation  as  well  as  defect
differentiation  of  lens  epithelial  cells  and  migration  of
dysplastic cells with retained nuclei and organelles to the
posterior pole have been discussed as pathogenic mechanisms
behind PSC formation [26,27]. Studies have shown that lens
differentiation as well as proliferation is controlled by growth
factors in the vitreous humor [28]. Alterations of these growth
factors by corticosteroids have been proposed to disturb lens
differentiation, providing a possible mechanism for steroid-
induced  effects  on  lens  fiber  differentiation  [15].  In  this
context, it is interesting to note the study by Creighton et al.
[5]  where  rat  lenses  incubated  with  methyl  prednisolone
developed PSC but the addition of vitamin E changed the
location of the opacity to the equator of the lens. This result
implies that steroids interfere with the differentiation process.
The expression of the human Ki-67 protein is strictly
associated with cell proliferation. It is present during all active
phases of the cell cycle (G1, S, G2) and during mitosis but is
absent  from  resting  cells  (G0)  [29].  When  studying
Figure 5. Mitochondrial membrane potential after dexamethasone
exposure.  Mitochondrial  membrane  potential  in  dexamethasone-
exposed human lens epithelial cells did not differ significantly from
the control group. The experiment was repeated eight times with
identical results. Changes in mitochondrial membrane potential are
expressed as the ratio of red signal (Ex 540 nm, Em 590 nm) to green
signal (Ex 485 nm and Em 535 nm). Mean ±SEM are given.
proliferation immunohistochemically with Ki-67, we found
increased  proliferation  in  cell  cultures  exposed  to
dexamethasone  at  low  concentrations.  Pro-proliferative
effects  of  steroids  have  previously  been  reported  [30,31],
although  data  are  contradictory  [32,33].  The  increase  in
proliferation as determined by Ki-67 expression in this study
is  in  contrast  to  the  decrease  of  viable  cells  seen  in
dexamethasone-exposed HLECs as examined by the MTT
assay. However, the MTT method detects all metabolically
active cells including cells in the G0 phase and is therefore a
measure of the total number of viable cells regardless of the
proportion of proliferating cells. Hence, increased apoptotic
response after dexamethasone exposure may be responsible
for the decreased number of viable cells as measured by the
MTT assay.
Previous studies in other cell types report conflicting data
on  steroid-induced  apoptosis.  Dexamethasone  has  been
shown both to induce apoptosis by activation of caspases
(proteases activated during apoptosis) [34] as well as to inhibit
apoptosis  [35].  This  study  uses  two  methods  to  measure
apoptotic changes in HLECs, studies of nuclear morphology
by Hoechst-staining and determination of caspase-3 activity,
both  demonstrating  an  increase  of  apoptosis  in
dexamethasone-exposed cells.
Cultured  human  lens  epithelial  cells  incubated  with
dexamethasone  did  not  exhibit  significantly  increased
superoxide  production,  and  peroxide  production  was  only
Figure 6. Effect of dexamethasone plus or minus the glucocorticoid
receptor  antagonist  RU486.  HLECs  were  incubated  with
dexamethasone at concentrations ranging from 0 to 100 µM for 24 h
with/without  10  µM  of  the  glucocorticoid  receptor  antagonist
RU-486, after which apoptosis was determined by the caspase-3
assay.  No  protection  of  human  lens  epithelial  cells  against
dexamethasone-induced  apoptosis  was  seen  by  10  µM  RU-486.
Instead,  simultaneous  incubation  with  RU-486  significantly
increased  the  proapoptotic  effect  seen  by  dexamethasone.  Cells
exposed to 10 µM RU-486 alone showed no increase in caspase-3
activity. Mean ±SEM from 3 separate culture wells are shown from
one of four experiments with similar results; the asterisk indicates a
p<0.05, the double asterisk indicates a p<0.01, and the triple asterisk
indicates a p<0.001.
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1349altered when exposed 100 µM dexamethasone. Furthermore,
GSH  levels  in  dexamethasone-exposed  HLECs  were  not
affected. These findings indicate that the increase of apoptosis
by dexamethasone was not primarily due to oxidative stress.
This is in contrast to a previous study by Dickerson, Dotzel,
and Clark [13] who found that dexamethasone significantly
decreased  GSH  levels  in  cultured  rat  lenses  already  at
exposure to 1 µM dexamethasone. In addition, Creighton et
al.  [5]  have  shown  that  the  addition  of  the  antioxidative
vitamin E decreases cataract induced by methyl prednisolone
in  cultured  rat  lenses,  further  supporting  oxidative
mechanisms in the formation of steroid cataract. Different
species and different experimental conditions may explain the
discrepancies in results as compared with the present study. It
is also likely that the use of whole lenses versus cultured lens
epithelial  cells  may  explain  this  difference  since  the  lens
epithelium is the most metabolically active part of the lens,
containing by far more antioxidative capacity than the rest of
the lens. Oxidative insults to an intact lens must hence rely to
a high degree on the epithelium for antioxidative defense.
When using lens epithelial cells to study mechanisms for
steroid cataract as in this study, one must bear in mind that
there are only lens epithelial cells on the anterior side of the
lens, and PSC, which is the cataract phenotype associated with
glucocorticoid exposure, is located on the posterior side of the
lens. However, the present study does not claim that cultured
HLECs exposed to dexamethasone should constitute a model
for steroid cataract, but they provide a useful way of studying
intracellular  effects  of  glucocorticoids  on  cultured  lens
epithelial cells. Of course, future studies on cultured whole
lenses  and  whole  animals  are  necessary  to  determine  the
pathogenic effects of steroids in a more complex biological
system. However, when using intact lenses, it is important to
monitor the integrity of the lenses, preferably by checking for
protein leakage as described both by Tumminia et al. [36] and
in a previous study from our group [37]. Other factors to take
into  consideration  when  setting  up  models  for  cataract
formation is that in vivo cataract development is a very slow
process and physiologically/clinically relevant models should
also develop during an extended period. Nagai et al. [15] used
systemic  pulse  administration  to  obtain  steroid-induced
cataract in brown Norway rats, a process that took 10 months
before any visible opacification of the lens could be seen.
Several investigators have also used cocataractogenic effects
by including additional cataractogenic factors in combination
with steroids in their cataract models. For instance, Shui et al.
[38]  developed  a  steroid  cataract  model  employing  a
combination  of  long-term  prednisolone  exposure  and  a
minimum  of  X-irradiation.  This  seems  like  a  relevant
approach  since  cataract  in  humans  is  considered  a
multifactorial disease.
It is well known that oxidative stress, among other effects,
causes  depolarization  of  the  mitochondria.  We  have
previously shown that the mitochondrial membrane potential
in HLECs is disrupted by hydrogen peroxide treatment [39].
However, exposure to dexamethasone up to 100 µM for 24 h
did not affect the mitochondrial membrane potential, which
further  supports  that  oxidative  stress  is  not  an  important
mechanism for dexamethasone-induced apoptosis in HLECs.
It might be of interest to note that another steroid (estradiol at
1 µM) may prevent the collapse of the mitochondrial potential
during  oxidative  stress  [40,41].  Estradiol  has  shown
antioxidative properties in several studies [42-44] whereas the
opposite has been reported for glucocorticoids [13,16].
The presence of a glucocorticoid receptor (GR) in the
mammalian lens has long been questioned [15]. However,
more recent studies have confirmed the existence of an active
GR  in  the  lens  [8,9,45-47].  Still,  the  mechanism  behind
activation of the GR and its contribution in steroid cataract
formation has not been elucidated.
In the present study, we investigated if inhibition of the
GR by 10 µM of the GR antagonist, RU-486, protected against
dexamethasone-induced  apoptosis.  No  such  anti-apoptotic
effect  was  seen  by  simultaneous  incubation  with
dexamethasone and RU-486. Instead, the results indicated that
RU-486 enhanced the proapoptotic effect of dexamethasone.
The concentration of RU-486 used (10 µM) was chosen after
performing dose-response experiments in cells subjected to
RU-486 alone. These experiments showed no apoptotic effect
of RU-486 at 10 µM or lower whereas higher concentrations
were proapoptotic by itself (data not shown). This finding was
also confirmed by microscopic examination of the cells (not
shown). However, several studies in cell types other than lens
epithelial cells have found a proapoptotic effect of RU-486 as
well as an inhibitory effect on cell proliferation [48-50]. Navo
et al. [50] proposed that the increase in apoptosis may be due
to p53 activation rather than hormone receptor inactivation. It
is possible that several signaling pathways are involved in
RU-486-mediated  apoptosis  as  well  as  in  glucocorticoid
response. In this study, the addition of RU-486 did not rescue
from  dexamethasone-induced  apoptosis,  but  instead,
apoptosis occurred at a lower concentration of dexamethasone
when  this  GR  inhibitor  was  present.  This  may  indicate
increased  vulnerability  of  the  HLECs  to  the  proapoptotic
effects of dexamethasone when simultaneously exposed to
RU-486.
Since there is a direct link between prolonged steroid use
and PSC, the present findings are of great importance for
elucidating  the  mechanism  behind  cortisone  cataract.
Dysregulation of apoptosis may also be a mechanism linking
corticosteroids to disturbances in lens fiber differentiation
since  the  differentiation  process  at  the  lens  equator  is
considered a limited form of apoptosis where the nuclei and
organelles  are  degraded  but  the  fibers  persist  [51-54].
Incomplete or defect differentiation of the lens fibers have
previously been implied in the formation of PSC [26] so
factors that affect the apoptotic process may contribute to or
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1350lead to PSC. As this study demonstrated increased apoptosis
in HLECs by dexamethasone, the present data supports the
hypothesis that apoptotic dysregulation may be an important
pathogenic mechanism in the formation of steroid-induced
posterior subcapsular cataract.
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